Skip to content

Acepromazine

NERVOUS SYSTEM

Also known as: acepromazin, acepromazine maleate, acetacin, acetazin, acetazine, acetopromazine, acetopromazine maleate, acetopromazine maleate salt, acetylpromazine, azepromazine

FDA approvedATC N05AA04

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Acepromazine is a drug catalogued in DrugCentral. DrugCentral lists 3 molecular targets, including PRNP, DRD1 and DRD2.

  • Molecular targets: PRNP, DRD1 and DRD2 (3 listed in DrugCentral).
  • ATC code: N05AA04 (Phenothiazines with aliphatic side-chain).
  • Molecular formula: C19H22N2OS; molecular weight 326.46 g/mol.

Mechanism & targets

Molecular targets (3)

TargetGeneActionActivity
Major prion proteinPRNPunknownEC50 5.30
D(1A) dopamine receptorDRD1antagonist—
D(2) dopamine receptorDRD2antagonist—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
—FDA——

ATC classification

ATC codeTherapeutic hierarchy
N05AA04NERVOUS SYSTEM › PSYCHOLEPTICS › ANTIPSYCHOTICS › Phenothiazines with aliphatic side-chain

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Acepromazine is on its molecule page.

Molecular formulaC19H22N2OS
Molecular weight326.46 g/mol
CAS number61-00-7
InChIKeyNOSIYYJFMPDDSA-UHFFFAOYSA-N
PubChem CID6077
CN(C)CCCN1C2=CC=CC=C2SC2=CC=C(C=C12)C(C)=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Acepromazine work?

Its molecular targets in DrugCentral include PRNP, DRD1 (antagonist) and DRD2 (antagonist).

What is the chemical formula of Acepromazine?

Acepromazine has the molecular formula C19H22N2OS and a molecular weight of 326.46 g/mol.

Browse: all drugs starting with A · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
AgencyFDA
Targets3
Indications0
FormulaC19H22N2OS
DrugCentral ID73
Interactive profile